Search Ontology:
ChEBI

sulfasalazine

Term ID
CHEBI:9334
Synonyms
  • 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid
  • 2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid
  • 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid
  • 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene
  • 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
  • 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid
  • 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid
  • Azulfidine
  • Salazosulfapiridina
  • Salazosulfapyridine
  • Salazosulfapyridinum
  • Salicylazosulfapyridine
  • Sulfasalazina
  • Sulfasalazine
  • Sulfasalazinum
Definition
An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
References
  • beilstein:356241
  • cas:599-79-1
  • drugbank:DB00795
  • gmelin:2666050
  • kegg.compound:C07316
  • kegg.drug:D00448
  • patent:US2396145
  • pdb-ccd:SAS
  • pubmed:11362329
  • pubmed:11485124
  • pubmed:11587223
  • pubmed:14981898
  • pubmed:15248210
  • pubmed:16322111
  • pubmed:17386570
  • pubmed:2434548
  • pubmed:7720170
  • reaxys:8132868
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from sulfasalazine
Phenotype where environments contain sulfasalazine
Phenotype modified by environments containing sulfasalazine
Phenotype affecting sulfasalazine
Human Disease Model